RIGEL PHARMACEUTICALS, INC. (RIGL) Operating income 2016–2025
RIGEL PHARMACEUTICALS, INC. (RIGL) annual operating income history from SEC filings — each fiscal year as reported.
$125.5MFY2025 · since FY2016: -$69.7M → $125.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $125.5M | +418.6% |
| FY2024 | $24.2M | +218.1% |
| FY2023 | -$20.5M | +63.1% |
| FY2022 | -$55.5M | -344.5% |
| FY2021 | -$12.5M | +56.9% |
| FY2020 | -$29.0M | +58.1% |
| FY2019 | -$69.1M | +4.9% |
| FY2018 | -$72.7M | +8.7% |
| FY2017 | -$79.6M | -14.2% |
| FY2016 | -$69.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RIGL financial trends
RIGL RevenueRIGL Net incomeRIGL Net marginRIGL Gross profitRIGL Gross marginRIGL Operating marginRIGL Operating cash flowRIGL Free cash flowRIGL Capital expendituresRIGL Return on equityRIGL Stock buybacksRIGL Dividends paidRIGL Total assetsRIGL Total liabilitiesRIGL Shareholders’ equityRIGL overview →